Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_05-cv-02116/USCOURTS-cand-3_05-cv-02116-6/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION AND [PROPOSED] ORDER RE TIME TO RESPOND TO COUNTERCLAIM 

Case No.: C 05 02116 MJJ

ALEXANDER L. BRAINERD (No. 42722) 

KEITH R. WEED (No. 95563) 

CHRISTINE SAUNDERS HASKETT (No. 188053) 

DUANE D. B. NASH (No. 220785) 

HELLER EHRMAN LLP 

333 Bush Street 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6000 

Facsimile: (415) 772-6268 

alexander.brainerd@hellerehrman.com 

keith.weed@hellerehrman.com 

christine.haskett@hellerehrman.com 

duane.nash@hellerehrman.com 

Attorneys for Plaintiffs 

ROCHE PALO ALTO LLC and ALLERGAN, INC. 

UNITED STATES DISTRICT COURT 

 NORTHERN DISTRICT OF CALIFORNIA 

ROCHE PALO ALTO LLC, formerly known 

as Syntex (U.S.A.) LLC, and 

ALLERGAN, INC., a Delaware corporation, 

Plaintiffs and Counter-Defendants, 

v. 

APOTEX, INC., a Canada corporation, and 

APOTEX CORP., a Delaware corporation, 

Defendants and Coutner-Plaintiffs. 

 Case No.: C 05 02116 MJJ

STIPULATION AND [PROPOSED] 

ORDER RE TIME TO RESPOND TO 

COUNTERCLAIM 

Case 3:05-cv-02116-MJJ Document 20 Filed 08/17/2005 Page 1 of 3 Case 3:05-cv-02116-MJJ Document 22 Filed 08/19/05 Page 1 of 3
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

STIPULATION AND [PROPOSED] ORDER RE TIME TO RESPOND TO COUNTERCLAIM 

Case No.: C 05 02116 MJJ

WHEREAS, on May 24, 2005, Plaintiffs and Counter-Defendants Roche Palo Alto LLC and 

Allergan, Inc. commenced the present action by filing a Complaint for infringement of United 

States Patent No. 5,110,493 (“the ’493 patent”) by Defendants and Counter-Plaintiffs Apotex, Inc. 

and Apotex, Corp. 

WHEREAS, on July 25, 2005, Defendants and Counter-Plaintiffs answered the Complaint 

and filed a Counterclaim seeking, inter alia, declaratory relief that the ‘493 patent be adjudged 

invalid and unenforceable. 

WHEREAS, on August 16, 2005, counsel for Plaintiffs and Counter-Defendants requested 

from counsel for Defendants and Counter-Plaintiffs that the deadline for filing Plaintiffs and 

Counter-Defendants’ response to the Counterclaim be postponed; 

WHEREAS, the parties wish to agree on a date certain for Plaintiffs and CounterDefendants to respond to the Counterclaim in this matter; and 

THEREFORE, by and through their respective undersigned counsels, the parties hereby 

stipulate that Plaintiffs and Counter-Defendants’ response to Defendants and Counter-Plaintiffs’ 

Counterclaim shall be due on August 26, 2005.

Case 3:05-cv-02116-MJJ Document 20 Filed 08/17/2005 Page 2 of 3 Case 3:05-cv-02116-MJJ Document 22 Filed 08/19/05 Page 2 of 3
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

STIPULATION AND [PROPOSED] ORDER RE TIME TO RESPOND TO COUNTERCLAIM 

Case No.: C 05 02116 MJJ

IT IS SO STIPULATED. 

DATED: August 17, 2005 _______/s/________________________

Alexander L. Brainerd 

HELLER EHRMAN LLP 

333 Bush Street, Suite 3000 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6000 

Facsimile: (415) 772-6268 

Attorneys for Plaintiffs and Counter-Defendants 

ROCHE PALO ALTO LLC and ALLERGAN, INC. 

DATED: August 17, 2005 ________/s/________________________

Ronald S. Lemieux 

PAUL, HASTINGS, JANOFSKY & WALKER LLP 

Five Palo Alto Square, Sixth Floor 

Palo Alto, CA 94306-2109 

Telephone: (650) 320-1821 

Facsimile: (650) 320-1921 

Attorney for Defendants and Counter-Plaintiffs 

APOTEX, INC. and APOTEX CORP.

PURSUANT TO STIPULATION, IT IS SO ORDERED. 

DATED: August ____, 2005 

The Honorable Martin J. Jenkins 

United States District Judge 

For the Northern District of California 

Case 3:05-cv-02116-MJJ Document 20 Filed 08/17/2005 Page 3 of 3

19

Case 3:05-cv-02116-MJJ Document 22 Filed 08/19/05 Page 3 of 3